@ARTICLE{
author={Vesovic Natasa V,Tosic Natasa M,Karan-Djurasevic Teodora Z,Andric Zoran G,Zdravkovic Darko D,Pavlovic Sonja T,Jovanovic Dragana D},
year={2026},
title={Expression pattern of circulating long non-coding RNA GAS5 as a novel biomarker in non-small cell lung cancer patients},
journal={ARCHIVES OF MEDICAL SCIENCE},
volume={22},
number={1},
pages={469-475},
document_type={Article},
} 

@ARTICLE{
author={Andric Zoran G,...,(broj koautora 16)},
year={2025},
title={Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer},
journal={CANCER TREATMENT AND RESEARCH COMMUNICATIONS},
volume={44},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Tobias Joshua,...,Andric Zoran G,...,Nikolic Ivan V,Petrovic Zoran,...,(broj koautora 17)},
year={2024},
title={Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)},
journal={CLINICAL CANCER RESEARCH},
volume={30},
number={18},
pages={4044-4054},
document_type={Article},
} 

@ARTICLE{
author={Reck Martin,...,Andric Zoran G,...,(broj koautora 24)},
year={2024},
title={Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study},
journal={LUNG CANCER},
volume={196},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Spigel David R,...,Stojanovic Goran,...,Andric Zoran G,...,(broj koautora 17)},
year={2024},
title={RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={42},
number={19},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Reck Martin,...,Andric Zoran G,...,(broj koautora 18)},
year={2024},
title={Avelumab Versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients With High-Expression Programmed Death-Ligand 1-Positive Metastatic NSCLC: Primary Analysis From the Phase 3 JAVELIN Lung 100 Trial},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={19},
number={2},
pages={297-313},
document_type={Article},
} 

@ARTICLE{
author={Andric Zoran G,...,Stojanovic Goran,Petrovic Marina D,...,(broj koautora 21)},
year={2023},
title={Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC},
journal={JTO CLINICAL AND RESEARCH REPORTS},
volume={4},
number={2},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Leal Ticiana A,...,Andric Zoran G,...,(broj koautora 25)},
year={2023},
title={Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study},
journal={LANCET ONCOLOGY},
volume={24},
number={9},
pages={1002-1017},
document_type={Article},
} 

@ARTICLE{
author={Verschraegen Claire,Andric Zoran G,Moiseenko Fedor,Makharadze Tamta,Shevnya Sergii,Oleksiienko Alona,Ruiz Eduardo Yanez,Kim SungHyun,Ahn KeumYoung,Park TaeHong,Park Sijin,Ju Hana,Ohe Yuichiro},
year={2022},
title={Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial},
journal={BIODRUGS},
volume={36},
number={6},
pages={749-760},
document_type={Article},
} 

@ARTICLE{
author={Goel Shom,Tan Antoinette R,Rugo Hope S,Aftimos Philippe,Andric Zoran G,Beelen Andrew Paul,Zhang Jingshan,Yi John S,Malik Rajesh K,O'Shaughnessy Joyce},
year={2022},
title={Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2},
journal={FUTURE ONCOLOGY},
volume={18},
number={33},
pages={3701-3711},
document_type={Article},
} 

@ARTICLE{
author={Peters Solange,...,Andric Zoran G,...,(broj koautora 26)},
year={2022},
title={Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial},
journal={NATURE MEDICINE},
volume={28},
number={9},
pages={1831-+},
document_type={Article},
} 

@ARTICLE{
author={Perovic-Blagojevic Iva M,Vekic Jelena Z,Macut Djuro P,Ignjatovic Svetlana D,Miljkovic-Trailovic Milica M,Zeljkovic Aleksandra R,Spasojevic-Kalimanovska Vesna V,Bozic-Antic Ivana B,Bjekic-Macut Jelica D,Kastratovic-Kotlica Biljana A,Andric Zoran G,Ilic Dusan S,Kotur-Stevuljevic Jelena M},
year={2022},
title={Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia},
journal={BRITISH JOURNAL OF NUTRITION},
volume={128},
number={4},
pages={604-612},
document_type={Article},
} 

@ARTICLE{
author={Weiss Jared,Goldschmidt Jerome,Andric Zoran G,Dragnev Konstantin H,Gwaltney Chad,Skaltsa Konstantina,Pritchett Yili,Antal Joyce M,Morris Shannon R,Daniel Davey},
year={2021},
title={Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies},
journal={CLINICAL LUNG CANCER},
volume={22},
number={5},
pages={449-460},
document_type={Article},
} 

@ARTICLE{
author={Jassem Jacek,...,Andric Zoran G,...,(broj koautora 19)},
year={2021},
title={Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC},
journal={JOURNAL OF THORACIC ONCOLOGY},
volume={16},
number={11},
pages={1872-1882},
document_type={Article},
} 

@ARTICLE{
author={Bjekic-Macut Jelica D,Vukasin Tamara,Velija-Asimi Zelija,Burekovic Azra,Zdravkovic Marija D,Andric Zoran G,Brankovic Marija S,Crevar-Marinovic Slobodanka,Madic Tatjana,Stanojlovic Olivera P,Milutinovic Danijela V,Livadas Sarantis,Mastorakos George},
year={2021},
title={Polycystic Ovary Syndrome: A Contemporary Clinical Approach},
journal={CURRENT PHARMACEUTICAL DESIGN},
volume={27},
number={36},
pages={3812-3820},
document_type={Review},
} 

@ARTICLE{
author={Syrigos Konstantinos,Abert Istvan,Andric Zoran G,Bondarenko Igor N,Dvorkin Mikhail,Galic Kristina,Galiulin Rinat,Kuchava Vladimer,Sriuranpong Virote,Trukhin Dmytro,Zhavrid Edvard,Fu Dongyue,Kassalow Laurent M,Jones Stephanie,Bashir Zahid},
year={2021},
title={Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)},
journal={BIODRUGS},
volume={35},
number={4},
pages={417-428},
document_type={Article},
} 

@ARTICLE{
author={Trukhin Dmytro,...,Andric Zoran G,...,(broj koautora 19)},
year={2021},
title={Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)},
journal={BIODRUGS},
volume={35},
number={4},
pages={429-444},
document_type={Article},
} 

@ARTICLE{
author={Hart Lowell L,Ferrarotto Renata,Andric Zoran G,Beck Thaddeus J,Subramanian Janakiraman,Radosavljevic Davorin Z,Zaric Bojan,Hanna Wahid T,Aljumaily Raid,Owonikoko Taofeek K,Verhoeven Didier,Xiao Jie,Morris Shannon R,Antal Joyce M,Hussein Maen A},
year={2021},
title={Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study},
journal={ADVANCES IN THERAPY},
volume={38},
number={1},
pages={350-365},
document_type={Article},
} 

@ARTICLE{
author={Kostic Sanja V,Murtezani Zafir,Andric Zoran G,Ivanovic Nebojsa S,Kozomara Zoran K,Kostic Marko I,Milicic Vesna M,Kocic Sanja S},
year={2020},
title={Assessment of age-related influences on the quality of life of breast cancer patients before and after surgical treatment},
journal={VOJNOSANITETSKI PREGLED},
volume={77},
number={9},
pages={908-916},
document_type={Article},
} 

@ARTICLE{
author={Herbst Roy S,...,Andric Zoran G,...,(broj koautora 22)},
year={2020},
title={Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC},
journal={NEW ENGLAND JOURNAL OF MEDICINE},
volume={383},
number={14},
pages={1328-1339},
document_type={Article},
} 

@ARTICLE{
author={Mansfield AS,...,Andric Zoran G,...,(broj koautora 19)},
year={2020},
title={Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial},
journal={ANNALS OF ONCOLOGY},
volume={31},
number={2},
pages={310-317},
document_type={Article},
} 

@ARTICLE{
author={Macut Djuro P,Mladenovic Violeta S,Bjekic-Macut Jelica D,Livadas Sarantis,Stanojlovic Olivera P,Hrncic Dragan R,Rasic-Markovic Aleksandra,Vojnovic-Milutinovic Danijela D,Andric Zoran G},
year={2020},
title={Hypertension in Polycystic Ovary Syndrome: Novel Insights},
journal={CURRENT HYPERTENSION REVIEWS},
volume={16},
number={1},
pages={55-60},
document_type={Review},
} 

@ARTICLE{
author={Macut Djuro P,Bjekic-Macut Jelica D,Livadas Sarantis,Stanojlovic Olivera P,Hrncic Dragan R,Rasic-Markovic Aleksandra,Vojnovic-Milutinovic Danijela D,Mladenovic Violeta S,Andric Zoran G},
year={2018},
title={Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome},
journal={CURRENT PHARMACEUTICAL DESIGN},
volume={24},
number={38},
pages={4593-4597},
document_type={Review},
} 

@ARTICLE{
author={Perovic-Blagojevic Iva M,Ignjatovic Svetlana D,Macut Djuro P,Kotur-Stevuljevic Jelena M,Bozic-Antic Ivana B,Vekic Jelena Z,Bjekic-Macut Jelica D,Kastratovic-Kotlica Biljana A,Andric Zoran G,Ilic Dusan S},
year={2018},
title={Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (The Doi Score) in Women with Polycystic Ovary Syndrome and Its Relationship with Obesity},
journal={JOURNAL OF MEDICAL BIOCHEMISTRY},
volume={37},
number={4},
pages={476-485},
document_type={Article},
} 

@ARTICLE{
author={Schwartzberg Lee Steven,Roeland E,Andric Zoran G,Kowalski Dariusz,Radic J,Voisin Daniel,Rizzi Giada,Navari R,Gralla Richard J,Karthaus Meinolf},
year={2018},
title={Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy},
journal={ANNALS OF ONCOLOGY},
volume={29},
number={7},
pages={1535-1540},
document_type={Article},
} 

@ARTICLE{
author={Bozic-Antic Ivana B,Ilic Dusan S,Bjekic-Macut Jelica D,Bogavac Tamara,Vojnovic-Milutinovic Danijela D,Kastratovic-Kotlica Biljana A,Milic Natasa M,Stanojlovic Olivera P,Andric Zoran G,Macut Djuro P},
year={2016},
title={Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome},
journal={EUROPEAN JOURNAL OF ENDOCRINOLOGY},
volume={175},
number={6},
pages={551-560},
document_type={Article},
} 

@ARTICLE{
author={Bjekic-Macut Jelica D,Radosavljevic Vojislav,Andric Zoran G,Ilic Dusan S,Stanojlovic Olivera P,Vojnovic-Milutinovic Danijela D,Bozic-Antic Ivana B,Zdravkovic Marija D,Hinic Sasa B,Macut Djuro P,Zarkovic Milos P},
year={2016},
title={Cortisol Response to Low-Dose (1 mu g) Acth Stimulation for the Prediction of Outcome in Patients with Systemic Inflammatory Response Syndrome},
journal={JOURNAL OF MEDICAL BIOCHEMISTRY},
volume={35},
number={4},
pages={428-435},
document_type={Article},
} 

@ARTICLE{
author={Macut Djuro P,Tziomalos Konstantinos,Bozic-Antic Ivana B,Bjekic-Macut Jelica D,Katsikis Ilias,Papadakis Efstathios,Andric Zoran G,Panidis Dimitrios},
year={2016},
title={Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome},
journal={HUMAN REPRODUCTION},
volume={31},
number={6},
pages={1347-1353},
document_type={Article},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Zaric Bojan,Andric Zoran G,...,(broj koautora 22)},
year={2015},
title={A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)},
journal={ANNALS OF ONCOLOGY},
volume={26},
number={8},
pages={1741-1748},
document_type={Article},
} 

@ARTICLE{
author={Macut Djuro P,Bacevic Marina,Bozic-Antic Ivana B,Bjekic-Macut Jelica D,Civcic Milorad,Erceg Snjezana,Vojnovic-Milutinovic Danijela D,Stanojlovic Olivera P,Andric Zoran G,Kastratovic-Kotlica Biljana A,Sukilovic Tijana},
year={2015},
title={Predictors of Subclinical Cardiovascular Disease in Women with Polycystic Ovary Syndrome: Interrelationship of Dyslipidemia and Arterial Blood Pressure},
journal={INTERNATIONAL JOURNAL OF ENDOCRINOLOGY},
volume={},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Sipetic-Grujicic Sandra B,Murtezani Zafir,Neskovic-Konstantinovic Zora B,Marinkovic Jelena M,Kovcin Vladimir N,Andric Zoran G,Kostic Sanja V,Ratkov Isidora S,Maksimovic Jadranka M},
year={2014},
title={Multivariate Analysis of Prognostic Factors in Male Breast Cancer in Serbia},
journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION},
volume={15},
number={7},
pages={3233-3238},
document_type={Article},
} 

@ARTICLE{
author={Andric Zoran G,Randjelovic Tomislav D,Kovcin Vladimir N,Gutovic Jasmina,Crevar Slobodanka,Murtezani Zafir,Kostic Sanja V},
year={2012},
title={Evaluation of the Efficacy and Toxicity of Protocol Cisplatin, 5-Fluorouracil, Leucovorin Compared to Protocol Fluorouracil, Doxorubicin and Mitomycin C in Locally Advanced and Metastatic Gastric Cancer},
journal={SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO},
volume={140},
number={5-6},
pages={305-312},
document_type={Article},
}